IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.144
AS - Asia 6.784
EU - Europa 4.981
SA - Sud America 1.128
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 6
Totale 38.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.998
SG - Singapore 3.210
CN - Cina 1.513
UA - Ucraina 1.369
BR - Brasile 932
IT - Italia 856
HK - Hong Kong 784
DE - Germania 710
SE - Svezia 651
TR - Turchia 480
VN - Vietnam 418
RU - Federazione Russa 366
IE - Irlanda 273
FI - Finlandia 216
GB - Regno Unito 189
IN - India 103
AR - Argentina 86
NL - Olanda 68
MX - Messico 60
CA - Canada 58
FR - Francia 48
AT - Austria 46
BD - Bangladesh 40
PL - Polonia 40
BE - Belgio 34
EC - Ecuador 32
ZA - Sudafrica 30
JP - Giappone 26
EU - Europa 25
IQ - Iraq 23
KR - Corea 23
ES - Italia 22
CZ - Repubblica Ceca 20
ID - Indonesia 19
CO - Colombia 18
UZ - Uzbekistan 18
MA - Marocco 17
PE - Perù 17
CL - Cile 16
PK - Pakistan 16
PY - Paraguay 12
RS - Serbia 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
AZ - Azerbaigian 9
LT - Lituania 9
PH - Filippine 9
DO - Repubblica Dominicana 8
JO - Giordania 8
CH - Svizzera 7
KE - Kenya 7
NP - Nepal 7
TN - Tunisia 7
VE - Venezuela 7
BO - Bolivia 6
DK - Danimarca 6
HU - Ungheria 6
IL - Israele 6
LV - Lettonia 6
AO - Angola 5
ET - Etiopia 5
GH - Ghana 5
RO - Romania 5
BG - Bulgaria 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
EG - Egitto 3
LK - Sri Lanka 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
AU - Australia 2
BH - Bahrain 2
BW - Botswana 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
MM - Myanmar 2
MZ - Mozambico 2
NI - Nicaragua 2
NO - Norvegia 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
Totale 38.144
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.251
Ann Arbor 1.932
Ashburn 1.903
Seattle 1.468
Chandler 1.364
Wilmington 1.309
Cambridge 1.302
Singapore 1.129
Dearborn 815
Hong Kong 777
Beijing 727
Jacksonville 686
Izmir 453
Boardman 431
Princeton 299
Dublin 270
Udine 190
Los Angeles 175
San Diego 175
Des Moines 163
Dong Ket 158
Dallas 127
Redondo Beach 118
Buffalo 108
Falls Church 94
Ho Chi Minh City 93
São Paulo 81
Milan 78
Andover 74
Hefei 68
Norwalk 64
Munich 63
New York 62
Hanoi 60
Nanjing 55
Ogden 51
Guangzhou 40
Kunming 40
Phoenix 38
Warsaw 36
Brussels 34
Rome 33
Nuremberg 32
Redmond 32
Shanghai 32
Rio de Janeiro 31
Grafing 30
Jinan 28
Fuzhou 26
Trieste 26
Frankfurt am Main 24
London 23
Tokyo 23
Council Bluffs 22
Santa Clara 22
Vienna 22
Belo Horizonte 21
Chennai 21
Chicago 21
Johannesburg 21
Bologna 20
Fremont 20
Mexico City 20
Montreal 20
Mumbai 20
Turin 20
Atlanta 18
Redwood City 18
Stockholm 18
Brooklyn 17
Curitiba 17
Denver 17
Nanchang 17
The Dalles 17
Venezia 17
Zhengzhou 17
Brno 16
Naples 16
Brasília 15
Buenos Aires 15
Wuhan 15
Boston 14
Da Nang 14
Haiphong 14
Helsinki 14
Orem 14
Porto Alegre 14
Toronto 14
Washington 14
Maserada Sul Piave 13
Tashkent 13
Hanover 12
Hebei 12
Ottawa 12
Poplar 12
Quito 12
Baghdad 11
Düsseldorf 11
Totale 27.455
Salva come PNG Salva come JPEG
Nome #
Terapia e profilassi delle infezioni 354
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 257
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 248
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 235
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 232
The management of multidrug-resistant enterobacteriaceae 227
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 223
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 213
Delafloxacin for the treatment of respiratory and skin infections 209
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 194
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 188
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 186
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 183
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 183
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 181
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 180
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 174
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 172
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 171
Advances in antibiotic therapy in the critically ill 170
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 169
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 169
Hot topics in necrotising skin and soft tissue infections 169
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 168
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 166
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 165
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 165
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 164
New therapeutic options for respiratory tract infections 164
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 163
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 163
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 162
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 162
Safety of long-term use of linezolid: Results of an open-label study 161
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 161
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 161
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 160
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 160
An Italian consensus for invasive candidiasis management (ITALIC) 160
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 159
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 159
Current and future therapies for invasive aspergillosis 158
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 158
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 158
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 158
Ceftolozane/tazobactam: place in therapy 158
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 157
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 157
The role of dalbavancin in skin and soft tissue infections 157
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 157
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 156
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 156
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 156
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 156
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 156
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 156
New therapeutic options for skin and soft tissue infections 155
Impact of new treatment options for hepatitis c virus infection in liver transplantation 155
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 154
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 154
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 154
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 153
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 153
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 153
Linezolid underexposure in a patient co-treated with venlafaxine 152
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 152
A survey on infection management practices in Italian ICUs 152
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 150
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 150
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 150
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 149
Development of novel antibacterial drugs to combat multiple resistant organisms 149
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 148
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 148
Prosthetic joints: Shining lights on challenging blind spots 148
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 148
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 147
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 147
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 147
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 146
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 146
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 146
Immunological profiles of HIV-positive recipients of liver transplant 146
Designing a pathogen-focused study to address the high unmet medical need represented by carbapenem-resistant gram-negative pathogens – the international, multicenter, randomized, open-label, phase 3 credible-cr study 146
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 145
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 145
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 145
Infective endocarditis in elderly: An Italian prospective multi-center observational study 144
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 144
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 144
Is there a future for tigecycline? 143
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems 143
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections 143
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 143
Are prophylactic antifungals in highly colonized patients safe and effective? 143
SDD and colistin resistance: End of a dream? 142
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 142
New antibiotics for bad bugs: Where are we? 142
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal 142
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 142
Totale 16.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.241 0 0 0 0 0 663 329 524 523 246 474 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20265.086 646 908 680 665 1.424 763 0 0 0 0 0 0
Totale 39.410